Amplicore lands key FDA approval for lead drug candidate


A biopharma company founded by a University of Cincinnati scientist has cleared a major hurdle with the Food and Drug Administration.

Previous All the details behind Meridian Bioscience's pending $1.53B acquisition
Next Modelo Health wants to end health disparities in pregnancy—with an app